CFMS - コンフォ―MIS （ConforMIS Inc.） コンフォ―MISCFMSのチャート
CFMSの企業情報
| symbol | CFMS |
|---|---|
| 会社名 | Conformis Inc （コンフォ―MIS） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Industrial Specialties |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 コンフォーMIS(ConforMIS Inc.)は医療技術会社である。同社はiFit Image-to-Implant技術プラットフォームを使用して、各患者の解剖学的構造に適合するように各サイズおよび形状の関節置換インプラントを開発・製造・販売する。同社のiFitテクノロジープラットフォームは、多様なジョイントに適用される。それは、患者の膝の自然な形状を復元するように設計されたカスタマイズされた膝インプラントのラインを提供する。同社のiFit技術プラットフォームは、カスタマイズされたインプラントを設計し、患者のコンピューター断層撮影スキャンに基づいてiJigと呼ばれる関連する使い捨ての患者固有の機器を設計し、患者用にカスタマイズされた手術計画（iView）を作成するために使用されるiFit Design、iJigを製造するために使用される3次元印刷技術であるiFit Printing、及びiFitジャストインタイムの製造・配送機能を提供する。 コンフォ―MISは米国の医療機器メ―カ―。独自の技術「iFit Image-to-Implant」プラットフォ―ムで、患者の骨格に合わせた形状の人口膝関節インプラントの開発、製造、販売を手掛ける。主要製品には「iTotal CR」、「iUni」、「iDuo」、「iPoly」などがある。本社はマサチュ―セッツ州ベッドフォ―ド。 Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which Conformis refers to as personalized, individualized, or sometimes as customized, to fit each patient's unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints. |
| 本社所在地 | 600 Technology Park Drive Billerica MA 01821 USA |
| 代表者氏名 | Kenneth Fallon ケネス・ファロン |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 781-345-9001 |
| 設立年月日 | 38047 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2015年 |
| 従業員数 | 350人 |
| url | www.conformis.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cfms |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -43.70400 |
| 終値（lastsale） | 0.93 |
| 時価総額（marketcap） | 58750463.13 |
| 時価総額 | 時価総額（百万ドル） 57.73339 |
| 売上高 | 売上高（百万ドル） 77.93200 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 40.87339 |
| 当期純利益 | 当期純利益（百万ドル） -50.36900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 ConforMIS Inc revenues decreased less than 1% to $38.8M. Net loss decreased 11% to $26.1M. Revenues reflect United States segment increase of 7% to $16.4M also reflect Germany (Country) segment decrease of 10% to $2.2M Rest of World segment decrease of 8% to $366K. Lower net loss reflects General and administrative - Other decrease of 19% to $11.1M (expense). |
CFMSのテクニカル分析
CFMSのニュース
How Conformis Inc. (NASDAQ: CFMS) Could Be A Loss Maker Since It Is Down -45.01% YTD? 2022/06/04 14:30:00 Marketing Sentinel
During the last session, Conformis Inc. (NASDAQ:CFMS)’s traded shares were 0.37 million, with the beta value of the company hitting 1.46. At the end of the trading day, the stock’s price was $0.42, reflecting an intraday gain of 7.36% or $0.03. The 52-week high for the CFMS share is $1.96, that puts it down -366.67 … How Conformis Inc. (NASDAQ: CFMS) Could Be A Loss Maker Since It Is Down -45.01% YTD? Read More »
Let’s Discuss The Conformis Inc. (NASDAQ: CFMS) Stock Forecast. 2022/06/01 16:00:00 Marketing Sentinel
In today’s recent session, 0.45 million shares of the Conformis Inc. (NASDAQ:CFMS) have been traded, and its beta is 1.46. Most recently the company’s share price was $0.37, and it changed around -$0.06 or -13.03% from the last close, which brings the market valuation of the company to $74.01M. CFMS at last check was trading … Let’s Discuss The Conformis Inc. (NASDAQ: CFMS) Stock Forecast. Read More »
Conformis Inc. (NASDAQ: CFMS): Can A Stock Be -43.39% Lower Year-To-Date And Still Be A Loser? 2022/05/28 15:00:00 Marketing Sentinel
Conformis Inc. (NASDAQ:CFMS)’s traded shares stood at 0.45 million during the last session, with the company’s beta value hitting 1.47. At the close of trading, the stock’s price was $0.43, to imply an increase of 7.16% or $0.03 in intraday trading. The CFMS share’s 52-week high remains $1.96, putting it -355.81% down since that peak … Conformis Inc. (NASDAQ: CFMS): Can A Stock Be -43.39% Lower Year-To-Date And Still Be A Loser? Read More »
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference 2022/05/10 12:00:00 GlobeNewswire
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in the H.C. Wainwright (HCW) Global Investment Conference.
Conformis, Inc. (CFMS) CEO Mark Augusti on Q1 2022 Results - Earnings Call Transcript 2022/05/04 19:04:03 Seeking Alpha
Conformis, Inc. (NASDAQ:NASDAQ:CFMS) Q1 2022 Earnings Conference Call May 04, 2022 08:30 AM ET Company Participants Mark Augusti - President and Chief Executive Officer Bob Howe - Chief…
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022 2022/04/11 20:30:00 GlobeNewswire
BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the market opens on Wednesday, May 4, 2022, at approximately 7:00 a.m. Eastern Time.
Conformis names michael fillion as chief operating officer (NASDAQ:CFMS) 2022/04/04 04:50:37 Seeking Alpha
Conformis (CFMS) has appointed Michael Fillion as its Chief Operating Officer
Conformis Inc. (NASDAQ: CFMS) On Friday – Up 21.88% From The Lows, What’s Next? 2022/04/02 14:00:00 Marketing Sentinel
During the last session, Conformis Inc. (NASDAQ:CFMS)’s traded shares were 0.32 million, with the beta value of the company hitting 1.43. At the end of the trading day, the stock’s price was $0.64, reflecting an intraday gain of 2.60% or $0.02. The 52-week high for the CFMS share is $1.96, that puts it down -206.25 … Conformis Inc. (NASDAQ: CFMS) On Friday – Up 21.88% From The Lows, What’s Next? Read More »
Oscillating Stock: Pyxis Tankers Inc. (NASDAQ:PXS), Conformis, Inc. (NASDAQ:CFMS) 2022/03/11 06:42:28 Stock Equity
Pyxis Tankers Inc. (NASDAQ:PXS) with the stream of 0.08% also noticed, India Conformis, Inc. (NASDAQ:CFMS) encountered a rapid change of -3.05% in the last hour of Thursday’s trading session. Pyxis … The post Oscillating Stock: Pyxis Tankers Inc. (NASDAQ:PXS), Conformis, Inc. (NASDAQ:CFMS) appeared first on Stocks Equity .
What Does 2022 Hold For Conformis Inc. (NASDAQ:CFMS)? 2022/03/05 19:00:00 Stocks Register
Conformis Inc. (NASDAQ:CFMS) price on Friday, March 04, rose 5.44% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.70. A look at the stock’s price movement, the close in the last trading session was $0.67, moving within a range at $0.6501 and $0.712. The beta value (5-Year … What Does 2022 Hold For Conformis Inc. (NASDAQ:CFMS)? Read More »
Alarming Stock: Conformis, Inc. (NASDAQ:CFMS), Isoray, Inc. (AMEX:ISR) 2021/12/24 04:47:18 Stock Equity
Conformis, Inc. (NASDAQ:CFMS) with the stream of -2.17% also noticed, India Isoray, Inc. (AMEX:ISR) encountered a rapid change of -2.17% in the last hour of Thursdays trading session. Conformis, Inc. The post Alarming Stock: Conformis, Inc. (NASDAQ:CFMS), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .
Traders should take notice on: 9 Meters Biopharma, Inc. (NASDAQ:NMTR), Conformis, Inc. (NASDAQ:CFMS) 2021/12/22 10:38:15 Stock Equity
9 Meters Biopharma, Inc. (NASDAQ:NMTR) with the stream of -1.62% also noticed, India Conformis, Inc. (NASDAQ:CFMS) encountered a rapid change of 6.60% in the last hour of Tuesdays trading session. The post Traders should take notice on: 9 Meters Biopharma, Inc. (NASDAQ:NMTR), Conformis, Inc. (NASDAQ:CFMS) appeared first on Stocks Equity .
Project Future Performance Before Investment: Conformis, Inc. (NASDAQ:CFMS), The Williams Companies, Inc. (NYSE:WMB) 2021/12/20 00:13:30 Stock Equity
Conformis, Inc. (NASDAQ:CFMS) with the stream of 14.89% also noticed, India The Williams Companies, Inc. (NYSE:WMB) encountered a rapid change of -1.34% in the last hour of Fridays trading session. The post Project Future Performance Before Investment: Conformis, Inc. (NASDAQ:CFMS), The Williams Companies, Inc. (NYSE:WMB) appeared first on Stocks Equity .
Heres What to Focus on: Conformis, Inc. (NASDAQ:CFMS), SOS Limited (NYSE:SOS) 2021/12/14 23:36:36 Stock Equity
Conformis, Inc. (NASDAQ:CFMS) with the stream of 2.78% also noticed, India SOS Limited (NYSE:SOS) encountered a rapid change of 0.98% in the last hour of Tuesdays trading session. Conformis, Inc. The post Heres What to Focus on: Conformis, Inc. (NASDAQ:CFMS), SOS Limited (NYSE:SOS) appeared first on Stocks Equity .
Asia Pacific Metal Trauma Implant Market to be valued at US$ 4,935.2 million in 2021 | Zimmer Biomet, Conformis, Smith & Nephew Plc., Stryker Corporation 2021/12/14 07:00:11 OpenPR
The Asia Pacific Metal Trauma Implant Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Asia Pacific Metal Trauma Implant Market report